NO20092123L - [F-18]-merket L-glutaminsyre, [F-18]-merket L-glutamin og derivater derav, anvendelse og fremgangsmate for fremstilling av disse - Google Patents

[F-18]-merket L-glutaminsyre, [F-18]-merket L-glutamin og derivater derav, anvendelse og fremgangsmate for fremstilling av disse

Info

Publication number: NO20092123L
Authority: NO; Norway
Prior art keywords: labelled; derivatives; glutamic acid; glutamine; preparation
Prior art date: 2006-11-01

Application number

NO20092123A

Other languages

English (en)

Norwegian (no)

Inventor

Ludger Dinkelborg

Matthias Friebe

Heribert Schmitt-Willich

Keith Graham

Lutz Lehmann

Raisa Nikolaevna Krasikowa

Yuri Belokon

Olga Fedorovna Kuznetsova

Mathias Berndt

Original Assignee

Inst Of The Human Brain Russia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-01

Filing date

2009-05-29

Publication date

2009-07-30

2006-11-01 Priority claimed from RU2006138584/04A external-priority patent/RU2395489C2/ru

2006-11-18 Priority claimed from EP06090211A external-priority patent/EP1923382A1/de

2009-05-29 Application filed by Inst Of The Human Brain Russia filed Critical Inst Of The Human Brain Russia

2009-07-30 Publication of NO20092123L publication Critical patent/NO20092123L/no

Links

WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 title abstract 5
229960002989 glutamic acid Drugs 0.000 title abstract 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 title 1
229930182816 L-glutamine Natural products 0.000 title 1
229930195714 L-glutamate Natural products 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/04—Nickel compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/04—Nickel compounds
- C07F15/045—Nickel compounds without a metal-carbon linkage
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

NO20092123A 2006-11-01 2009-05-29 [F-18]-merket L-glutaminsyre, [F-18]-merket L-glutamin og derivater derav, anvendelse og fremgangsmate for fremstilling av disse NO20092123L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
RU2006138584/04A RU2395489C2 (ru)	2006-11-01	2006-11-01	[f-18] меченная l-глютаминовая кислота, [f-18] меченный l-глютамин, их производные и их применение, а также способ их получения
EP06090211A EP1923382A1 (de)	2006-11-18	2006-11-18	[F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung
PCT/EP2007/009518 WO2008052788A1 (de)	2006-11-01	2007-10-30	[f-18] markierte l-glutaminsäure, [f-18] markiertes l-glutamin, ihre derivate und ihre verwendung sowie verfahren zu ihrer herstellung

Publications (1)

Publication Number	Publication Date
NO20092123L true NO20092123L (no)	2009-07-30

Family

ID=38896929

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20092123A NO20092123L (no)	2006-11-01	2009-05-29	[F-18]-merket L-glutaminsyre, [F-18]-merket L-glutamin og derivater derav, anvendelse og fremgangsmate for fremstilling av disse

Country Status (23)

Country	Link
US (2)	US20100217011A1 (es)
EP (1)	EP2086924B1 (es)
JP (4)	JP5529540B2 (es)
KR (1)	KR101495924B1 (es)
CN (1)	CN101595083B (es)
AR (1)	AR071043A1 (es)
AU (1)	AU2007315203B2 (es)
BR (1)	BRPI0718055A2 (es)
CA (1)	CA2667395C (es)
CL (2)	CL2007003169A1 (es)
CO (1)	CO6180453A2 (es)
CU (1)	CU23825B1 (es)
EA (1)	EA017713B1 (es)
EC (1)	ECSP099304A (es)
ES (1)	ES2701423T3 (es)
IL (1)	IL198022A0 (es)
MX (1)	MX2009004686A (es)
NO (1)	NO20092123L (es)
NZ (1)	NZ576582A (es)
PE (1)	PE20091723A1 (es)
SV (1)	SV2009003251A (es)
TW (1)	TWI415626B (es)
WO (1)	WO2008052788A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2123621A1 (de) *	2008-05-20	2009-11-25	Bayer Schering Pharma Aktiengesellschaft	Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung
NZ576582A (en)	2006-11-01	2011-12-22	Bayer Schering Pharma Ag	[f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
EP2123620A1 (en) *	2008-05-20	2009-11-25	Bayer Schering Pharma Aktiengesellschaft	{F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
EP2123619A1 (de) *	2008-05-20	2009-11-25	Bayer Schering Pharma AG	Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
CA2736861C (en)	2008-10-10	2017-11-14	Roger Schibli	18f-labelled folates as pet radiotracers
US8722014B2 (en) *	2009-05-01	2014-05-13	Washington University	1 H-[1, 2, 3] triazole substituted amino acids and uses thereof
CN102595888A (zh) *	2009-08-14	2012-07-18	宾夕法尼亚大学理事会	4-氟谷氨酰胺的单一非对映异构体及其制备方法和应用
EP2322171A3 (en) *	2009-11-17	2011-06-01	Bayer Schering Pharma Aktiengesellschaft	Fluorine labeled L-glutamic acid derivatives
CN102711841A (zh) *	2009-11-17	2012-10-03	拜耳医药股份有限公司	碘标记的高谷氨酸和谷氨酸衍生物
CA2780930A1 (en)	2009-11-17	2011-05-26	Mathias Berndt	Method for production of f-18 labeled glutamic acid derivatives
EP2338892A1 (en) *	2009-12-18	2011-06-29	Bayer Schering Pharma Aktiengesellschaft	Prostate specific membrane antigen inhibitors
US9139316B2 (en)	2010-12-29	2015-09-22	Cardinal Health 414, Llc	Closed vial fill system for aseptic dispensing
EP2520557A1 (en)	2011-05-03	2012-11-07	Bayer Pharma Aktiengesellschaft	Novel precursors of glutamate derivatives
EP2520556A1 (en)	2011-05-03	2012-11-07	Bayer Pharma Aktiengesellschaft	Radiolabeled amino acids for diagnostic imaging
WO2013012813A1 (en)	2011-07-15	2013-01-24	Cardinal Health 414, Llc	Modular cassette synthesis unit
WO2013012822A1 (en)	2011-07-15	2013-01-24	Cardinal Health 414, Llc	Systems, methods, and devices for producing, manufacturing, and control of radiopharmaceuticals
US9417332B2 (en)	2011-07-15	2016-08-16	Cardinal Health 414, Llc	Radiopharmaceutical CZT sensor and apparatus
US20130022525A1 (en) *	2011-07-15	2013-01-24	Cardinal Health 414, Llc	Methods and compositions for drying in the preparation of radiopharmaceuticals
WO2020010228A1 (en) *	2018-07-06	2020-01-09	The Regents Of The University Of California	Deconstructive functionalization methods and compounds
CN109369445B (zh) *	2018-11-20	2021-10-15	首都医科大学	用于诊断和治疗的放射性谷氨酰胺衍生物及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1461184A (fr) *	1964-12-23	1966-01-07	Takeda Chemical Industries Ltd	Procédé de préparation d'isoxazolidones substituées en position 5
DE1620522A1 (de) *	1964-12-23	1970-04-23	Takeda Chemical Industries Ltd	Verfahren zur Herstellung von 5-substituierten Isoxazolidonverbindungen
US5264570A (en) *	1992-08-05	1993-11-23	General Electric Company	Method for making 2-[18 F]fluoro-2-deoxy-D-glucose
US5267570A (en) *	1992-12-30	1993-12-07	Preston Myra S	Method of diagnosing and treating chronic fatigue syndrome
GB9324872D0 (en)	1993-12-03	1994-01-19	Univ Pasteur	Pharmaceutical compounds
US6459003B1 (en) *	1999-04-01	2002-10-01	Esperion Therapeutics, Inc.	Ether compounds
AU2001278945A1 (en)	2000-08-10	2002-02-25	Eli Lilly And Company	4-substituted d-glutamic acid derivatives for use as antibiotic
AU2001288658A1 (en)	2000-09-01	2002-03-13	Annovis, Inc.	Screen for glutamate reuptake inhibitors, stimulators, and modulators
DE10223451A1 (de) *	2002-05-25	2003-12-24	Abx Gmbh	Verfahren zur Herstellung von 18F-fluorierten alpha-Aminosäuren
CN100581589C (zh) *	2002-08-02	2010-01-20	马林克罗特公司	放射标记的氨基酸类似物,其制备物及用途
DE10346228B4 (de) *	2003-09-25	2009-04-09	Eberhard-Karls-Universität Tübingen Universitätsklinikum	Herstellung von [18F]fluormarkierten aromatischen L-Aminosäuren
US7270799B2 (en) *	2004-01-15	2007-09-18	Nst Neurosurvival Technologies Ltd.	Perturbed membrane-binding compounds and methods of using the same
US7483732B2 (en)	2004-04-15	2009-01-27	Boston Scientific Scimed, Inc.	Magnetic resonance imaging of a medical device and proximate body tissue
US20070011016A1 (en) *	2005-07-07	2007-01-11	Alderman Joseph B	Springing interests flowing from benefits that run with land
EP2123621A1 (de)	2008-05-20	2009-11-25	Bayer Schering Pharma Aktiengesellschaft	Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP1923382A1 (de)	2006-11-18	2008-05-21	Bayer Schering Pharma Aktiengesellschaft	[F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung
NZ576582A (en)	2006-11-01	2011-12-22	Bayer Schering Pharma Ag	[f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
EP2123619A1 (de) *	2008-05-20	2009-11-25	Bayer Schering Pharma AG	Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123620A1 (en) *	2008-05-20	2009-11-25	Bayer Schering Pharma Aktiengesellschaft	{F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them

2007
- 2007-10-30 NZ NZ576582A patent/NZ576582A/en not_active IP Right Cessation
- 2007-10-30 BR BRPI0718055-1A2A patent/BRPI0718055A2/pt not_active IP Right Cessation
- 2007-10-30 EP EP07819544.3A patent/EP2086924B1/de active Active
- 2007-10-30 CA CA2667395A patent/CA2667395C/en not_active Expired - Fee Related
- 2007-10-30 ES ES07819544T patent/ES2701423T3/es active Active
- 2007-10-30 MX MX2009004686A patent/MX2009004686A/es active IP Right Grant
- 2007-10-30 KR KR20097009017A patent/KR101495924B1/ko not_active Expired - Fee Related
- 2007-10-30 JP JP2009535027A patent/JP5529540B2/ja not_active Expired - Fee Related
- 2007-10-30 US US12/513,112 patent/US20100217011A1/en not_active Abandoned
- 2007-10-30 AU AU2007315203A patent/AU2007315203B2/en not_active Ceased
- 2007-10-30 CN CN200780040971.7A patent/CN101595083B/zh not_active Expired - Fee Related
- 2007-10-30 WO PCT/EP2007/009518 patent/WO2008052788A1/de not_active Ceased
- 2007-10-30 EA EA200970428A patent/EA017713B1/ru not_active IP Right Cessation
- 2007-11-01 TW TW096141249A patent/TWI415626B/zh not_active IP Right Cessation
- 2007-11-01 AR ARP070104863A patent/AR071043A1/es not_active Application Discontinuation
- 2007-11-02 CL CL200703169A patent/CL2007003169A1/es unknown
2008
- 2008-04-23 PE PE2008000696A patent/PE20091723A1/es not_active Application Discontinuation
2009
- 2009-04-06 IL IL198022A patent/IL198022A0/en unknown
- 2009-04-30 CO CO09043963A patent/CO6180453A2/es not_active Application Discontinuation
- 2009-04-30 EC EC2009009304A patent/ECSP099304A/es unknown
- 2009-04-30 SV SV2009003251A patent/SV2009003251A/es unknown
- 2009-05-04 CU CU20090072A patent/CU23825B1/es not_active IP Right Cessation
- 2009-05-29 NO NO20092123A patent/NO20092123L/no not_active Application Discontinuation
2012
- 2012-03-28 CL CL2012000768A patent/CL2012000768A1/es unknown
2013
- 2013-12-02 JP JP2013249418A patent/JP2014088389A/ja active Pending
- 2013-12-02 JP JP2013249417A patent/JP5815651B2/ja not_active Expired - Fee Related
2014
- 2014-01-13 US US14/153,491 patent/US9375497B2/en not_active Expired - Fee Related
- 2014-06-10 JP JP2014119836A patent/JP5749836B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP5749836B2 (ja)	2015-07-15
CN101595083A (zh)	2009-12-02
US20140301948A1 (en)	2014-10-09
EP2086924B1 (de)	2018-09-12
CL2007003169A1 (es)	2008-07-04
JP2014221764A (ja)	2014-11-27
CL2012000768A1 (es)	2012-09-14
JP2014062113A (ja)	2014-04-10
MX2009004686A (es)	2009-09-28
AU2007315203A1 (en)	2008-05-08
ES2701423T3 (es)	2019-02-22
ECSP099304A (es)	2009-07-31
JP2014088389A (ja)	2014-05-15
JP2010508317A (ja)	2010-03-18
TWI415626B (zh)	2013-11-21
EA017713B1 (ru)	2013-02-28
CA2667395A1 (en)	2008-05-08
WO2008052788A1 (de)	2008-05-08
EP2086924A1 (de)	2009-08-12
CA2667395C (en)	2016-05-10
BRPI0718055A2 (pt)	2013-11-05
US20100217011A1 (en)	2010-08-26
TW200920407A (en)	2009-05-16
AR071043A1 (es)	2010-05-26
CU20090072A7 (es)	2011-09-21
PE20091723A1 (es)	2009-12-11
JP5529540B2 (ja)	2014-06-25
CU23825B1 (es)	2012-06-21
KR20090096597A (ko)	2009-09-11
NZ576582A (en)	2011-12-22
US9375497B2 (en)	2016-06-28
JP5815651B2 (ja)	2015-11-17
AU2007315203B2 (en)	2013-06-27
EA200970428A1 (ru)	2009-12-30
KR101495924B1 (ko)	2015-02-25
HK1138568A1 (en)	2010-08-27
SV2009003251A (es)	2009-12-15
CN101595083B (zh)	2014-12-10
CO6180453A2 (es)	2010-07-19
IL198022A0 (en)	2009-12-24

Legal Events

Date	Code	Title	Description
2017-05-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
MX2009004686A (es)	2009-09-28	Acido l-glutamico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, asi como procedimientos para su preparacion.
WO2009141091A8 (de)	2010-11-11	Neue [f-18] -markierte l-glutaminsäure- und l-glutaminderivate (i), ihre verwendung sowie verfahren zu ihrer herstellung
MY151986A (en)	2014-07-31	Adamantyl diamide derivatives and uses of same
NO20092412L (no)	2009-08-19	Hydantoinderivater anvendes som MMP-inhibitorer
MX2009000884A (es)	2009-06-05	Derivados de piridizinona.
MX2009012082A (es)	2009-12-01	Compuestos de ariloazol-2-il cianoetilamino, metodo para prepararlos y metodo para utilizarlos.
MX2009007713A (es)	2009-07-29	Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
NO20081217L (no)	2008-04-15	Nye benzotiazolonderivater
NO20080129L (no)	2008-01-08	Fremgangsmate for fremstilling av dihydrokinazoliner
NO20073572L (no)	2007-09-12	Nye forbindelser
NO20083845L (no)	2008-12-11	2,4-diaminopyrimidiner som celle-cyklus kinase inhibitorer
ECSP066376A (es)	2006-11-16	FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
NO20083708L (no)	2008-09-23	4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
MX2010009022A (es)	2010-09-07	Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
CR20110031A (es)	2011-03-14	NUEVOS DERIVADOS DE IMIDAZO [1,2-a]PIRIMIDINA, SU PROCEDIMIENTO DE PREPARACIÓN, SU APLICACIÓN COMO MEDICAMENTOS, COMPOSICIONES FARMACÉUTICAS Y NUEVA UTILIZACIÓN PARTICULARMENTE COMO INHIBIDORES DE MET
BRPI0507903A (pt)	2007-07-10	derivados de quinazolina e composição farmacêutica compreendendo os mesmos
NO20081169L (no)	2008-03-05	Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20080468L (no)	2008-02-22	Diazepinokinoliner, synteser av disse samt intermediater
NO20084301L (no)	2008-12-12	Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
MX2011006095A (es)	2011-09-22	Dihidroetorfina y su preparacion.
WO2009141079A8 (de)	2010-11-18	Neue [f-18]-markierte l-glutaminsäure- und l-glutaminderivative (ii), ihre verwendung sowie verfahren zu ihrer herstellung
CY1113279T1 (el)	2016-04-13	Φαρμακευτικη συνθεση 271
UY29510A1 (es)	2006-12-29	Derivados de urea, metodos para su fabricación, y usos de los mismos
TW200640863A (en)	2006-12-01	Compounds which potentiate glutamate receptor and uses thereof in medicine
NO20064344L (no)	2006-10-19	Caspaseinhibitorer og anvendelser derav